Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators... see more

TSX:QIPT - Post Discussion

Quipt Home Medical Corp > Raymond James expects 30mil equity raise - dilution coming?
View:
Post by besttobe on Jan 07, 2023 8:05am

Raymond James expects 30mil equity raise - dilution coming?

VALUATION We update our models (Ex. 1) in which we conservatively assume a 3% organic growth rate, and no additional M&A through 2023 as QIPT’s management team—whom we’ve come to appreciate as very strong operators (yet another reason for right-sizing of QIPT’s valuation multiple)— ensures the acquisition of Great Elm is neatly and fully integrated. Also, while management indicated that the carrying cost of the $73 mln debt is very manageable given QIPT’s ~2.0 debt/ equity ratio, we conservatively assume a near-term $30 mln equity raise @ $9/sh deriving a proforma FD sh. count of 42.5 mln. As such, we roll forward our valuation of QIPT to a blended 10x 2023E EV/EBITDA and 8x 2024E EV/EBITDA multiple (corrected from previous inaccurate 12x and 10x resp.)
Comment by lscfa on Jan 07, 2023 11:35am
This post has been removed in accordance with Community Policy
Comment by lscfa on Jan 07, 2023 3:27pm
lame bashing.  New equity at $9 US for accretive deals is not dilutive.
Comment by ValueRider on Jan 08, 2023 12:12am
This post has been removed in accordance with Community Policy
Comment by besttobe on Jan 08, 2023 8:58am
Maybe the right answer would be, instead of juvenile insults, is there will be no equity raises and Raymond James is just hoping to make some money. There is no need for an equity raise. This year Quipt will be focusing on fully intergrating the GEG and doing s few tuck ins. Also trying to make the company profitable and FCF positive now that they reach scale to prove the model. They have plenty ...more  
Comment by gibbonsj on Jan 08, 2023 1:38pm
I like the idea of $9/share because that's where share price will settle and then move up from there on the next acquisition or financial report.
Comment by HatrikSeLaine on Jan 09, 2023 8:27am
As a reminder if this so-called equity future raise occurs, Raymond James is predicting it happens at $9 USD ($12 CAD).   $30 million USD of dilution at that point is going to look like chump change given the 60% upswing in CAD share price form here.
Comment by Carlito3311 on Jan 09, 2023 10:08am
This post has been removed in accordance with Community Policy
Comment by checkup on Jan 09, 2023 1:26pm
$7.50 cad  is way too cheap .........IMO ...... doubtful that wil happen.
Comment by Tropicalsun on Jan 09, 2023 3:55pm
It just goes to show what a guy misses reading some of these reports, if in fact you don't take the time to read them carefully. Totally missed the statement by RJ that conservatively we assume a near term equity raise at $9 ish for 30 million bucks.  An oddly worded statement in my view and how the hell would they just assume this? Near term in my books means fairly soon, stock trading ...more  
Comment by HatrikSeLaine on Jan 09, 2023 4:28pm
My thoughts exactly TropicalSun.   $12 CAD is light years away from $7 CAD and at that point the dilution is quite small on $30 million (if it ever even happens).   I just wanted all in this board to be quite clear in this one footnote from one analyst's personal thoughts as to what may or may not happen.  Also, please don't let the bashers totally embellish these or ...more  
Comment by lscfa on Jan 10, 2023 1:35pm
All the analysts have underestimated impact of CPI rate increase on ebitda. They have assumed historical margin of ~20%
Comment by ValueRider on Jan 10, 2023 1:44pm
ISCFA, the rate increase won't be reflected in Q1 numbers right? Going to be Q2 numbers that show that right?
Comment by lscfa on Jan 10, 2023 1:57pm
correct
Comment by Tropicalsun on Jan 10, 2023 2:23pm
I would agree with that statement, quite frankly it puzzles me as to why. These analyst's do have the resources, (money, staff ) to get the job done correctly. Probably lazy, or don't see it as that big a deal. However if you are correct in your dd, the CPI adjustment should go straight to the bottom line.
Comment by lscfa on Jan 10, 2023 2:50pm
Beacon comment: The CPI positive price adjustment of ~8% on Medicare and contracts tied to Medicare that took effect January 1, 2023. This will impact ~40% of QIPT’s revenue but also ~35-40% of Great Elm’s business. 8% of $220 million equates to $6-$7 million of incremental revenue over-and-above that $220 million level. Given the higher costs (ie. labour, equipment) have already been ...more  
Comment by Carlito3311 on Jan 10, 2023 7:35pm
This post has been removed in accordance with Community Policy
Comment by lscfa on Feb 17, 2023 10:51am
Updated report removes assumption of an equity raise.   https://quipthomemedical.com/file/2021/05/RJ-QIPT-FQ123-02.14.23.pdf
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities